首页> 美国卫生研究院文献>ACS AuthorChoice >Preparation of Microcrystals of Piroxicam Monohydrateby Antisolvent Precipitation via Microfabricated Metallic Membraneswith Ordered Pore Arrays
【2h】

Preparation of Microcrystals of Piroxicam Monohydrateby Antisolvent Precipitation via Microfabricated Metallic Membraneswith Ordered Pore Arrays

机译:一水吡罗昔康微晶的制备通过超细金属膜的反溶剂沉淀有序孔阵列

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Microcrystals of piroxicam (PRX) monohydrate with a narrow size distribution were prepared from acetone/PRX solutions by antisolvent crystallization via metallic membranes with ordered pore arrays. Crystallization was achieved by controlled addition of the feed solution through the membrane pores into a well-stirred antisolvent. A complete transformation of an anhydrous form I into a monohydrate form of PRX was confirmed by Raman spectroscopy and differential scanning calorimetry. The size of the crystals was 7–34 μm and was controlled by the PRX concentration in the feed solution (15–25 g L–1), antisolvent/solvent volume ratio (5–30), and type of antisolvent (Milli-Q water or 0.1–0.5 wt % aqueous solutions of hydroxypropyl methyl cellulose (HPMC), poly(vinyl alcohol) or Pluronic P-123). The smallest crystals were obtained by injecting 25 g L–1 PRX solution through a stainless-steel membrane with a pore size of 10 μm into a 0.06 wt % HPMC solution stirred at 1500 rpm using an antisolvent/solvent ratio of 20. HPMC provided better steric stabilization of microcrystals against agglomeration than poly(vinyl alcohol) and Pluronic P-123, due to hydrogen bonding interactionswith PRX and water. A continuous production of large PRX monohydratemicrocrystals with a volume-weighted mean diameter above 75 μmwas achieved in a continuous stirred membrane crystallizer. Rapidpouring of Milli-Q water into the feed solution resulted in a mixtureof highly polydispersed prism-shaped and needle-shaped crystals.
机译:由丙酮/ PRX溶液通过有序孔阵列的金属膜通过反溶剂结晶从丙酮/ PRX溶液中制备了具有窄尺寸分布的吡罗昔康(PRX)一水合物微晶。通过控制进料溶液通过膜孔加入到充分搅拌的抗溶剂中来实现结晶。拉曼光谱和差示扫描量热法证实无水形式I完全转化为PRX一水合物形式。晶体的大小为7–34μm,并受进料溶液中PRX浓度(15–25 g L –1 ),抗溶剂/溶剂体积比(5–30)和类型的抗溶剂(Milli-Q水或羟丙基甲基纤维素(HPMC),聚乙烯醇或Pluronic P-123的0.1-0.5 wt%水溶液)。通过将25 g L -1 PRX溶液通过孔径为10μm的不锈钢膜注入到使用抗溶剂/溶剂以1500 rpm搅拌的0.06 wt%HPMC溶液中获得最小的晶体。比率为20。由于氢键相互作用,HPMC提供了比聚(乙烯醇)和Pluronic P-123更好的微晶抗结块空间稳定性。用PRX和水。连续生产大型PRX一水合物体积加权平均直径大于75μm的微晶在连续搅拌的膜结晶器中获得了R 2。快速将Milli-Q水倒入进料溶液中产生混合物高度分散的棱柱形和针状晶体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号